Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
Randomized phase III trial to determine the effectiveness of carboxyamidotriazole in treating
patients who have stage III or stage IV non-small cell lung cancer. Chemotherapeutic agents
are modestly effective for the treatment of advanced lung cancer, with rapid tumor relapse
and growth even after initial response to therapy. It is not yet known whether
carboxyamidotriazole is more effective than no further treatment after standard chemotherapy
for non-small cell lung cancer.